Free tool

Diagnostics stocks

We cover 16 companies grouped under the Diagnostics theme. The median market value in the group is $151.94M. Across the group, the median move over the past trading day is +0.03%. Price change over the past year runs from −53.3% to +85.1% across the middle 80 percent of the group, with a median of −15.6%.

Other lists in this group

Table

16 of 150 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
CSTLCastle Biosciences, Inc.$1.02BSmall cap+70.15%
IDX.AXIntegral Diagnostics Limited$638.89MSmall cap−17.78%
CEVI.STCellaVision AB (publ)$413.78MSmall cap−3.32%
ACL.AXAustralian Clinical Labs Limited$386.24MSmall cap+12.06%
YDESYD Bio Ltd$331.49MSmall cap−64.97%
0RAR.LStratec SE$275.63MSmall cap−13.37%
XGNExagen Inc.$184.11MSmall cap−22.84%
4671.TFALCO HOLDINGS Co., Ltd.$179.10MSmall cap+21.25%
BVXP.LBioventix PLC$124.78MSmall cap−30.64%
PRPOPrecipio, Inc.$55.23MMicro cap+117.41%
RIBBRibbon Acquisition Corp.$54.52MMicro cap+6.62%
ABDX.LAbingdon Health Plc$37.08MMicro cap+100.00%
RENX.LRenalytix Plc$25.64MMicro cap−27.35%
GSS.AXGenetic Signatures Limited$13.51MMicro cap−72.33%
CNSL.LCambridge Nutritional Sciences plc$6.17MMicro cap−41.54%
BIAFbioAffinity Technologies, Inc.$3.14MMicro cap−30.52%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse